의약품 제제 시장 : 제형별, 적응증별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 예측(2024-2032년)

REPORT HIGHLIGHT

Drug Formulation Market size was valued at USD 1,759,023.43 Million in 2023, expanding at a CAGR of 6.01% from 2024 to 2032.

The drug formulation market involves the development and production of medications in various forms, like tablets, capsules, and injections. It focuses on combining active ingredients with other substances to create effective and safe drugs. This market plays a crucial role in healthcare by ensuring that medicines can deliver the right dosage and work effectively in the body. Companies in this market conduct research to improve existing drugs and develop new ones. The goal is to provide better treatments for various diseases and conditions. Overall, the drug formulation market is essential for advancing medicine and improving patient care.

Drug Formulation Market- Market Dynamics

Rising demand for personalized medicine and targeted therapies drives growth

Rising demand for personalized medicine and targeted therapies is driving growth in the drug formulation market. Personalized medicine tailors' treatments to individual patient needs, improving outcomes and efficiency. According to the National Institutes of Health (NIH), over 1,800 active clinical trials are focusing on personalized therapies.

This shift highlights the importance of creating tailored treatments for various patient groups. Educational institutions also contribute by researching new formulations and treatment strategies. As healthcare evolves, the emphasis on personalized approaches is likely to expand, benefiting both patients and the drug formulation industry.

Drug Formulation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.01% over the forecast period (2024-2032)

Based on Dosage Form segmentation, Oral formulations was predicted to show maximum market share in the year 2023

Based on Indication segmentation, Infectious Diseases was the leading type in 2023

Based on End User segmentation, Big Pharma Companies was the leading type in 2023

Based on Region, North America was the leading revenue generator in 2023

Drug Formulation Market- Segmentation Analysis:

The Global Drug Formulation Market is segmented based on Dosage Form, Indication, End User, and Region.

The market is divided into three categories based on Dosage Form: Oral formulations, Parenteral formulations, Topical formulations, and Inhalation formulations. Oral formulations are the most prominent segment. This category includes various forms like tablets and capsules, which are widely used due to their convenience and ease of administration. Among these, tablets, especially immediate-release ones, are highly popular because they are simple to produce and have a long shelf life. Oral formulations are preferred by both patients and healthcare providers for their effectiveness and comfort, making them the dominant choice in the market.

The market is divided into two categories based on Indication: Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, and Others. Infectious diseases represent the most prominent segment. This is largely due to the ongoing need for effective treatments and vaccines, especially highlighted by recent global health crises like the COVID-19 pandemic. The demand for antiviral and antibiotic drugs remains high as healthcare systems focus on preventing and treating infections. Additionally, the rapid development of new therapies in this area drives innovation and investment, making infectious diseases a dominant focus in drug formulation.

Drug Formulation Market- Geographical Insights

The North American drug formulation market is very important and is growing quickly. The United States is the largest part of this market, with many pharmaceutical companies developing new medicines. These companies focus on creating safe and effective drug formulations to treat various health issues. Advances in technology and research are helping improve drug delivery methods. Canada is also contributing by supporting research and innovation in the healthcare sector. Additionally, strict regulations ensure high-quality standards for drug formulations. Overall, North America plays a crucial role in shaping the future of the drug formulation market.

Drug Formulation Market- Competitive Landscape:

The drug formulation market is competitive, with major players like Pfizer, Johnson & Johnson, and Roche leading the way. These companies invest heavily in research and development to create new and effective medications. Merck & Co. and Bristol-Myers Squibb are also significant competitors, focusing on innovative therapies. GSK and Novartis contribute with their strong product portfolios and global reach. Additionally, companies like AbbVie and Amgen are known for their specialty drugs. The market is constantly evolving, driven by advancements in technology and changing healthcare needs. This competition fosters innovation and helps bring better treatments to patients.

Recent Developments:

In September 2024, Sanofi, RadioMedix, and Orano Med announced a licensing agreement for a next-generation radioligand treatment aimed at rare cancers. This collaboration focuses on advancing innovative therapies for patients with these specific conditions.

In May 20224 Novartis has agreed to acquire Mariana Oncology, boosting its radioligand therapy pipeline. This strategic move enhances Novartis's capabilities in developing targeted cancer treatments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DRUG FORMULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Pfizer
• Johnson & Johnson
• Roche
• Merck & Co.
• Bristol-Myers Squibb
• GSK (GlaxoSmithKline)
• Novartis
• AbbVie
• Sanofi
• Amgen
• AstraZeneca
• Bayer
• Teva Pharmaceutical Industries
• Mylan
• Celgene

GLOBAL DRUG FORMULATION MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

• Oral formulations
• Tablets
• Immediate Release
• Modified Release
• Chewable
• Effervescent
• Capsules
• Hard Gelatine Capsules
• Soft gel Capsules
• Others
• Powders & Granules
• Lozenges & Pastilles
• Gummies
• Others
• Parenteral formulations
• Solutions
• Suspensions
• Emulsions for injection or infusion
• Powders for injection or infusion
• Gels for injection implants
• Topical formulations
• Pastes
• Ointments and oils
• Creams, lotions, and foams.
• Gels, tinctures, and powders
• Sprays and patches
• Inhalation formulations
• Pressurized Metered Dose Inhaler
• Dry Powder Inhaler (DPI)
• Nebulizer

GLOBAL DRUG FORMULATION MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

• Infectious Diseases
• Cancer
• Cardiovascular Diseases
• Diabetes
• Respiratory Diseases
• Central Nervous System Disorders
• Others

GLOBAL DRUG FORMULATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

• Big Pharma Companies
• Small & Medium Size Pharma Companies
• Biotech Companies

GLOBAL DRUG FORMULATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Drug Formulation Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Drug Formulation Market Snippet by Dosage Form
  • 2.1.2. Drug Formulation Market Snippet by Indication
  • 2.1.3. Drug Formulation Market Snippet by End User
  • 2.1.4. Drug Formulation Market Snippet by Country
  • 2.1.5. Drug Formulation Market Snippet by Region
• 2.2. Competitive Insights

3. Drug Formulation Key Market Trends

• 3.1. Drug Formulation Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Drug Formulation Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Drug Formulation Market Opportunities
• 3.4. Drug Formulation Market Future Trends

4. Drug Formulation Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Drug Formulation Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Drug Formulation Market Landscape

• 6.1. Drug Formulation Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Drug Formulation Market - By Dosage Form

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
  • 7.1.2. Oral formulations
    • 7.1.2.1. Tablets
    • 7.1.2.1.1. Immediate Release
    • 7.1.2.1.2. Modified Release
    • 7.1.2.1.3. Chewable
    • 7.1.2.1.4. Effervescent
    • 7.1.2.2. Capsules
    • 7.1.2.2.1. Hard Gelatine Capsules
    • 7.1.2.2.2. Soft gel Capsules
    • 7.1.2.2.3. Others
    • 7.1.2.3. Powders & Granules
    • 7.1.2.4. Lozenges & Pastilles
    • 7.1.2.5. Gummies
    • 7.1.2.6. Others
  • 7.1.3. Parenteral formulations
    • 7.1.3.1. Solutions
    • 7.1.3.2. Suspensions
    • 7.1.3.3. Emulsions for injection or infusion
    • 7.1.3.4. Powders for injection or infusion
    • 7.1.3.5. Gels for injection implants
  • 7.1.4. Topical formulations
    • 7.1.4.1. Pastes
    • 7.1.4.2. Ointments and oils
    • 7.1.4.3. Creams, lotions, and foams.
    • 7.1.4.4. Gels, tinctures, and powders
    • 7.1.4.5. Sprays and patches
  • 7.1.5. Inhalation formulations
    • 7.1.5.1. Pressurized Metered Dose Inhaler
    • 7.1.5.2. Dry Powder Inhaler (DPI)
    • 7.1.5.3. Nebulizer

8. Drug Formulation Market - By Indication

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
  • 8.1.2. Infectious Diseases
  • 8.1.3. Cancer
  • 8.1.4. Cardiovascular Diseases
  • 8.1.5. Diabetes
  • 8.1.6. Respiratory Diseases
  • 8.1.7. Central Nervous System Disorders
  • 8.1.8. Others

9. Drug Formulation Market - By End User

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
  • 9.1.2. Big Pharma Companies
  • 9.1.3. Small & Medium Size Pharma Companies
  • 9.1.4. Biotech Companies

10. Drug Formulation Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Drug Formulation Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Drug Formulation Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Drug Formulation Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Drug Formulation Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Drug Formulation Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Drug Formulation Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Pfizer
  • 11.2.2. Johnson & Johnson
  • 11.2.3. Roche
  • 11.2.4. Merck & Co.
  • 11.2.5. Bristol-Myers Squibb
  • 11.2.6. GSK (GlaxoSmithKline)
  • 11.2.7. Novartis
  • 11.2.8. AbbVie
  • 11.2.9. Sanofi
  • 11.2.10. Amgen
  • 11.2.11. AstraZeneca
  • 11.2.12. Bayer
  • 11.2.13. Teva Pharmaceutical Industries
  • 11.2.14. Mylan
  • 11.2.15. Celgene

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us